Kipps, T., Perini, G., Lavie, D., Bigni, R., Navarro-Bailón, A., Benjamini, O., Fineman, R., Schneider, C., Assouline, S., Owen, C., Masszi, A., Dupont, J., Edmondson, M., Chen, C., Cristescu, R., Myer, N., Xu, Y., Yang, J., Farooqui, M. Z., Jurczak, W. (2025). Genomic assessment of acquired mutations in participants with CLL/SLL treated with nemtabrutinib in the Phase 2 bellwave-003 study. Blood. https://doi.org/10.1182/blood-2025-797